Search Results - molecular+medicine

1 Results

Sort By:

Method to Enhance Treatment of Metastatic Melanoma with BRAF Inhibitors

Malignant melanoma is the most lethal form of skin cancer and accounts for almost 80% of skin cancer deaths. About 60% of melanomas have a mutation in the BRAF oncogene at V600E. The FDA recently approved (January 2014) the combination of a BRAF inhibitor (Dabrafenib) and a MEK 1/2 inhibitor (Trametinib) to treat this type of melanoma. A problem...

Published: 7/2/2018 | Inventor(s): Sanjay Srivastava, Neel Fofaria

Keywords(s): Cancer, Medicine, Molecular Medicine, Therapeutics

Category(s): Cancer Therapeutics, Pharmaceutical, Therapeutics